1.A pathologic study of abdominal lymphangiomas.
Jin Haeng CHUNG ; Yeon Lim SUH ; In Ae PARK ; Ja June JANG ; Je Geun CHI ; Yong Il KIM ; Woo Ho KIM
Journal of Korean Medical Science 1999;14(3):257-262
Abdominal lymphangiomas are uncommon angiomatous tumor occurring mainly in childhood. This is a retrospective clinicopathologic study of 17 cases of abdominal lymphangioma. The patients included are five children and 12 adults, with a mean age at initial presentation of 30.7 years (age ranges 3-63). The locations of the tumors were mesentery (5), retroperitoneum (4), colon (3), omentum (3), mesocolon (1) and gallbladder (1). Infiltrative growth was more common pattern than entirely circumscribed pattern. Masses were mostly multilocular cysts and contained chyle or serous fluid. On immunohistochemical staining, 16 cases were reactive for either CD31 or factor VIII-related antigen. These fact would suggest that intra-abdominal lymphangiomas simulate the immunohistochemical features of collecting lymphatics. Follow up was possible in 12 cases for 3-50 months (mean 19 months) and only one patient showed local recurrence. Although abdominal lymphangiomas are rare in adulthood and correct preoperative diagnosis is difficult, awareness of such a possibility in adulthood will contribute to make a correct preoperative diagnosis.
Abdominal Neoplasms/physiopathology
;
Abdominal Neoplasms/pathology*
;
Abdominal Neoplasms/metabolism
;
Adult
;
Antigens, CD31/biosynthesis
;
Child
;
Child, Preschool
;
Factor VIII/biosynthesis
;
Female
;
Human
;
Lymphangioma/physiopathology
;
Lymphangioma/pathology*
;
Lymphangioma/metabolism
;
Male
;
Middle Age
;
Retrospective Studies
2.COMP-Angiopoietin-1 Promotes Cavernous Angiogenesis in a Type 2 Diabetic Rat Model.
Sun Ouck KIM ; Hyun Suk LEE ; Kyuyoun AHN ; Kwangsung PARK
Journal of Korean Medical Science 2013;28(5):725-730
Cartilage oligomeric matrix protein-angiopoietin-1 (COMP-Ang1) is an angiogenic factor for vascular angiogenesis. The aim was to investigate the effect of an intracavernosal injection of COMP-Ang1 on cavernosal angiogenesis in a diabetic rat model. Male Otsuka Long-Evans Tokushima Fatty (OLETF) rats made up the experimental group (1 yr old) and Long-Evans Tokushima Otsuka (LETO) rats made up the control group. The experimental group was divided into vehicle only, 10 microg COMP-Ang1, and 20 microg COMP-Ang1. COMP-Ang1 was injected into the corpus cavernosum of the penis. After 4 weeks, the penile tissues of the rats were obtained for immunohistochemistry and Western blot analysis. The immunoreactivity of PECAM-1 and VEGF was increased in the COMP-Ang1 group compared with the vehicle only group. Moreover, the expression of PECAM-1 and VEGF was notably augmented in the 20 microg Comp Ang-1 group. In the immunoblotting study, the expression of PECAM-1 and VEGF protein was significantly less in the OLEFT rats than in the control LETO rats. However, this expression was restored to control level after intracavernosal injection of COMP-Ang1. These results show that an intracavernosal injection of COMP-Ang1 enhances cavernous angiogenesis by structurally reinforcing the cavernosal endothelium.
Angiopoietin-1/genetics/*metabolism
;
Animals
;
Antigens, CD31/metabolism
;
Blood Glucose/analysis
;
Blotting, Western
;
Body Weight
;
Cartilage Oligomeric Matrix Protein/genetics/*metabolism
;
Diabetes Mellitus, Experimental/*pathology
;
Immunohistochemistry
;
Male
;
Neovascularization, Physiologic/*drug effects
;
Penis/metabolism/pathology
;
Rats
;
Rats, Long-Evans
;
Recombinant Fusion Proteins/biosynthesis/genetics/*pharmacology
;
Vascular Endothelial Growth Factor A/metabolism